By identifying precise changes in a patient’s cancer, such as issues with DNA repair, specific proteins like HSF1, ERs, and TOPK, or mechanisms by which the cancer evades the immune system, clinicians can select medications likely to be most effective for each individual. Here, HSF1 is linked to cancer.